Recent advances in the treatment of thromboembolic diseases: Venous thromboembolism

被引:6
作者
Agrawal, Y. K.
Vaidya, Hitesh
Bhatt, Hardik
Manna, Kuntal
Brahmkshatriya, Pathik
机构
[1] Nirma Univ Sci & Technol, Inst Pharm, Ahmadabad 382481, Gujarat, India
[2] LM Coll Pharm, Dept Med Chem, Ahmadabad 380009, Gujarat, India
关键词
venous thromboembolic; antiplatelets; thrombolytics; pharmacoeconomics;
D O I
10.1002/med.20100
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Venous thromboembolic diseases are the major concern of rising cost of healthcare and are commonest health problem across the globe. Both genetic and acquired risk factors are believed to be strongly linked with these diseases. Commonly encountered problems to the therapy include dose fixing and routine monitoring, yet some serious problems of bleeding also necessitate the immediate need to develop new agents. The review is primarily concerned with the new developments in the treatment of thromboembolic diseases. Therapeutic applications of anticoagulants, antiplatelets, and thrombolytics have been discussed in enough detail. (C) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:891 / 914
页数:24
相关论文
共 183 条
  • [1] Clinical status of direct thrombin inhibitors
    Agnelli, G
    Sonaglia, F
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1999, 31 (02) : 97 - 117
  • [2] A NEW LOW-MOLECULAR WEIGHT HEPARIN DERIVATIVE - INVITRO AND INVIVO STUDIES
    AIACH, M
    MICHAUD, A
    BALIAN, JL
    LEFEBVRE, M
    WOLER, M
    FOURTILLAN, J
    [J]. THROMBOSIS RESEARCH, 1983, 31 (04) : 611 - 621
  • [3] [Anonymous], 1974, NEW ENGL J MED, V290, P15
  • [4] [Anonymous], 1970, J AMER MED ASSOC, V214, P2163
  • [5] [Anonymous], 1995, PROPHYLAXIS VENOUS T
  • [6] [Anonymous], 1991, ANESTHESIOLOGY
  • [7] [Anonymous], 1998, Thrombosis and Emboli
  • [8] [Anonymous], CHEST
  • [9] Managing oral anticoagulant therapy
    Ansell, J
    Hirsh, J
    Dalen, J
    Bussey, H
    Anderson, D
    Poller, L
    Jacobson, A
    Deykin, D
    Matchar, D
    [J]. CHEST, 2001, 119 (01) : 22S - 38S
  • [10] COMPARATIVE PHARMACOKINETICS OF A LOW-MOLECULAR WEIGHT HEPARIN (PK-10-169) AND UNFRACTIONATED HEPARIN AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION
    BARA, L
    BILLAUD, E
    GRAMOND, G
    KHER, A
    SAMAMA, M
    [J]. THROMBOSIS RESEARCH, 1985, 39 (05) : 631 - 636